Background: Heart failure (HF) presents a massive burden to health care with a complex pathophysiology that results in HF with reduced left ventricle ejection fraction (EF) or HF with preserved EF. It has been shown that relatively modest changes in protein glycosylation, an essential posttranslational modification, are associated with clinical presentations of HF. We and others previously showed that such aberrant protein glycosylation in animal models can lead to HF. Methods and Results: We develop and characterize a novel, tamoxifen‐inducible, cardiomyocyte Mgat1 knockout mouse strain, achieved through deletion of Mgat1 , alpha‐1,3‐mannosyl‐glycoproten 2‐beta‐N‐acetlyglucosaminyltransferase, which encodes N‐acetylglucosaminyltransferase I. We investigate the role of hybrid/complex N‐glycosylation in adult HFrEF pathogenesis at the ion channel, cardiomyocyte, tissue, and gross cardiac level. The data demonstrate successful reduction of N‐acetylglucosaminyltransferase I activity and confirm that hybrid/complex N‐glycans modulate gating of cardiomyocyte voltage‐gated calcium channels. A longitudinal study shows that the tamoxifen‐inducible, cardiomyocyte Mgat1 knockout mice present with significantly reduced systolic function by 28 days post induction that progresses into HFrEF by 8 weeks post induction, without significant ventricular dilation or hypertrophy. Further, there was minimal, if any, physiologic or pathophysiologic cardiomyocyte electromechanical remodeling or fibrosis observed before (10–21 days post induction) or after (90–130 days post induction) HFrEF development. Conclusions: The tamoxifen‐inducible, cardiomyocyte Mgat1 knockout mouse strain created and characterized here provides a model to describe novel mechanisms and causes responsible for HFrEF onset in the adult, likely occurring primarily through tissue‐level reductions in electromechanical activity in the absence of (or at least before) cardiomyocyte remodeling and fibrosis.
Laser speckle contrast imaging (LSCI) is a wide-field, optical technique capable of assessing changes in flow rates of scattering fluids. In biomedical applications, LSCI has been used to quantify changes of blood perfusion in various tissue. One limitation of LSCI is its limited depth sensitivity- it can only sense blood flow in superficial layers of tissue. The goal of this study was to experimentally investigate the depth-sensitivity of LSCI for detecting fluid flow embedded in a turbid optical phantom. LSCI was used to image a flow channel buried by the scattering medium at incremental depths ranging from 0 mm to 2.4 mm. The flow measurements were successively repeated using two illumination wavelengths, 633 nm and 785 nm. Images were captured with and without flow present through the phantom for each wavelength and analyzed to develop a flow-sensitivity parameter. This provided a metric of LSCI’s ability for detecting flow as a function of channel depth. At a depth of 1.5 mm, the flow sensitivity decreased by 80% with the 633 nm illumination and 65% for the 785 nm illumination relative to a depth of 0 mm. The results demonstrate that the flow sensitivity of the 785 nm source diminished at a slower rate as the buried depth was increased than the sensitivity of the 633 nm source. This study suggests that the flow depth and illumination wavelength should be considered while using LSCI.
16 December 2025 in Journal of the American Heart Association
Background: Lipin1 has dual functions acting as phosphatidic acid phosphatase required for lipid synthesis and as a transcriptional coactivator. Our previous research demonstrated that lipin1 is critical for maintaining sarcolemmal integrity in skeletal muscle. Given the importance of sarcolemmal stability for cardiac muscle viability and function, we investigated the role of lipin1 in the heart using a novel cardiac‐specific lipin1 deficient ( Myh6‐lipin1−/− ) mouse model. Methods: We characterized male Myh6‐lipin1−/− mice at 3 to 4 months of age to assess cardiac structure and function. Results: Myh6‐lipin1−/− mice exhibited marked cardiac inflammation, fibrosis, increased expression of cell death markers, and elevated sarcolemmal damage. Lipin1 deficiency led to disrupted sarcolemmal integrity, evidenced by decreased expression and mislocalization of key membrane structural proteins. Upon isoproterenol‐induced cardiac stress, lipin1‐deficient mice demonstrated significantly greater reductions in ejection fraction and fractional shortening compared with control mice. Conclusions: These findings reveal a critical role for lipin1 in maintaining cardiac sarcolemmal integrity and emphasize its importance in supporting normal cardiac morphology and function, particularly under stress conditions.